Trial Outcomes & Findings for Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF (NCT NCT02141360)

NCT ID: NCT02141360

Last Updated: 2017-07-24

Results Overview

To determine associations between clinical neurological data, MR images, quantitative data from novel software post-processing (sponsor developed software including Volumetry, Kurtosis, Resting State \[RS\], functional magnetic resonance imaging \[fMRI\], and additional post-processing modules may be provided

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

17 participants

Primary outcome timeframe

Baseline to 3 months

Results posted on

2017-07-24

Participant Flow

Volunteer Control participants were scanned only for the purpose of operator training and calibrating the MRI device. No data was collected from these participants for the the purpose of analysis.

Participant milestones

Participant milestones
Measure
Experimental: Diagnostic mTBI
MRI Diagnostic of subjects with mild Traumatic Brain Injury (mTBI) MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Experimental: Diagnostic Non mTBI
MRI Diagnostic of Non injured subjects that are closely matched to mTBI MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Volunteer Controls
Non injured volunteers for device calibration Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Overall Study
STARTED
11
6
6
Overall Study
COMPLETED
4
6
6
Overall Study
NOT COMPLETED
7
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Experimental: Diagnostic mTBI
MRI Diagnostic of subjects with mild Traumatic Brain Injury (mTBI) MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Experimental: Diagnostic Non mTBI
MRI Diagnostic of Non injured subjects that are closely matched to mTBI MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Volunteer Controls
Non injured volunteers for device calibration Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Overall Study
Withdrawal by Subject
6
0
0
Overall Study
Study Terminated before Visit
1
0
0

Baseline Characteristics

Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Experimental: Diagnostic mTBI
n=11 Participants
MRI Diagnostic of subjects with mild Tramatic Brain Injury (mTBI) MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Experimental: Diagnostic Non mTBI
n=6 Participants
MRI Diagnostic of Non injured subjects that are closely matched to mTBI MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Total
n=17 Participants
Total of all reporting groups
Age, Categorical
<=18 years
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
n=5 Participants
6 Participants
n=7 Participants
15 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
3 Participants
n=7 Participants
6 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
3 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
United States
11 Participants
n=5 Participants
6 Participants
n=7 Participants
17 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline to 3 months

Population: Study was terminated and no subject outcome data were collected

To determine associations between clinical neurological data, MR images, quantitative data from novel software post-processing (sponsor developed software including Volumetry, Kurtosis, Resting State \[RS\], functional magnetic resonance imaging \[fMRI\], and additional post-processing modules may be provided

Outcome measures

Outcome measures
Measure
Experimental: Diagnostic mTBI
MRI Diagnostic of subjects with mild Traumatic Brain Injury (mTBI) MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Experimental: Diagnostic Non mTBI
MRI Diagnostic of Non injured subjects that are closely matched to mTBI MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
Volunteer Controls
Non injured volunteers for device calibration Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences
mTBI Progression Indicated by Clinical Neurological Characteristics, MRI Images, and Quantitative MRI Data From Novel Software
0
0
0

Adverse Events

Experimental: Diagnostic mTBI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Experimental: Diagnostic Non mTBI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Volunteer Controls

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Chief Medical Officer - Head Health Initiative

GE Healthcare

Phone: 262-544-3633

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place